48 Results for "

TTR

" in MedChemExpress (MCE) Product Catalog:
Products (48)

48 Results for "TTR" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-132589
CAS No.: 1867157-35-4
Synonyms: ALN-TTRsc02
Vutrisiran (ALN-TTRsc02) is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran can be used for transthyretin (TTR)-mediated amyloidosis research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-132589A
Purity:  96.37%
Synonyms: ALN-TTRsc02 sodium
Vutrisiran sodium (ALN-TTRsc02 sodium) is a liver-directed small interfering RNA (siRNA). Vutrisiran sodium targets the mRNA of transthyretin (TTR), and is applicable to studies on transthyretin (TTR)-mediated amyloidosis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N1957
CAS No.: 31271-07-5
Synonyms: γ-Mangostin
Gamma-Mangostin is a novel competitive 5-hydroxytryptamine 2A (5-HT2A) receptor antagonist and potent epoxidase 2 (COX-2) inhibitor, as well as a transthyroxin protein (TTR) profibrosis inhibitor. Gamma-Mangostin binds to the thyroxine (T4)-binding sites and stabilized the TTR tetramer . Gamma-Mangostin inhibits [3 H] spiperone binding to cultured rat aortic myocytes (IC50=3.5 nM) and reduces The perfusion pressure response of rat coronary artery to 5-HT2A (IC50=0.32 μM). Gamma-Mangostin has anti-inflammatory, antibacterial, antioxidant and anticancer activities, and can be used in the study of metabolic disorders such as diabetes .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14852
CAS No.: 594839-88-0
Purity:  99.89%
Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14852A
CAS No.: 951395-08-7
Purity:  99.79%
Synonyms: Fx-1006A
Target:  

Transthyretin (TTR)

Research Areas:  

Neurological Disease

Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis meglumine inhibits amyloidogenesis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-132609
CAS No.: 1386913-72-9
Purity:  99.09%
Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113283
CAS No.: 451-13-8
Purity:  99.46%
Homogentisic acid is an orally active, blood-brain barrier-permeable amyloidogenic compound that functions as both an amyloid component and a pigment precursor. Accumulation of homogentisic acid downregulates tight junction proteins (such as claudin-5, occludin, ZO-1) and impairs blood-brain barrier integrity. Homogentisic acid and its oxidation product benzoquinone acetic acid not only induce the aggregation and fibrosis of multiple proteins (such as 1-42, α-synuclein, SAA, Transthyretin (TTR), atrial natriuretic peptide), but also trigger oxidative stress, damage to the Wnt/β-catenin pathway, and neurotoxicity, leading to ochronosis pigment deposition and synaptic dysfunction. At specific concentrations, homogentisic acid exerts no cytotoxicity or genotoxicity on human peripheral blood lymphocytes, and even counteracts the genotoxicity induced by Irinotecan (HY-16562). Homogentisic acid serves as an important tool molecule for investigating the mechanisms of diseases including ochronosis, secondary amyloidosis, Alzheimer's disease, and colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148089
CAS No.: 1637600-16-8
Target:  

Transthyretin (TTR)

Research Areas:  

Neurological Disease

Eplontersen is a triantennary N-acetyl galactosamine (GalNAc3-7a)-conjugated antisense oligonucleotide targeting transthyretin (TTR) mRNA to inhibit production of both variant and wild-type TTR protein. Misfolded TTR induces amyloid fibrils formation in the heart and peripheral nerves, leads to amyloid TTR (ATTR) amyloidosis diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148089A
CAS No.: 2131025-75-5
Purity:  96.92%
Target:  

Transthyretin (TTR)

Research Areas:  

Neurological Disease

Eplontersen sodium the sodium salt form of Eplontersen (HY-148089). Eplontersen sodium is a triantennary N-acetyl galactosamine (GalNAc3-7a)-conjugated antisense oligonucleotide targeting transthyretin (TTR) mRNA to inhibit production of both variant and wild-type TTR protein. Misfolded TTR induces amyloid fibrils formation in the heart and peripheral nerves, leads to amyloid TTR (ATTR) amyloidosis diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P73580
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Transthyretin; ATTR; Prealbumin; TBPA; TTR; PALB
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-132608
CAS No.: 1432726-13-0
Purity:  96.44%
Synonyms: ISIS-420915 sodium
Target:  

Transthyretin (TTR)

Research Areas:  

Neurological Disease

Inotersen (ISIS-420915) sodium is a 2′-O-methoxyethyl-modified antisense oligonucleotide. Inotersen sodium inhibits the production of transthyretin (TTR) protein by targeting the TTR RNA transcript and reduces the levels of the TTR transcript. Inotersen sodium can be used for the research of hereditary TTR amyloidosis polyneuropathy .
loading...
    loading...
Cat. No.: HY-112974
CAS No.: 1492984-65-2
Synonyms: GSK-2998728; ISIS-420915
Inotersen (GSK-2998728; ISIS-420915) is a 2'-O-methoxyethyl-modified antisense oligonucleotide and transthyretin (TTR) inhibitor with low genotoxicity. Inotersen triggers RNase H1-mediated degradation by binding to TTR mRNA, thereby effectively reducing the production of both mutant and wild-type transthyretin in the liver. Inotersen significantly reduces amyloid fiber deposition, yet specific toxicities such as inflammation or tumors are observed at high doses in some animal models. Inotersen is used in studies of hereditary transthyretin amyloidosis and the associated polyneuropathy and cardiomyopathy .
loading...
    loading...
Cat. No.: HY-P991128
CAS No.: 2965214-50-8
Synonyms: NI-006; ALXN2220
Cliramitug (NI-006; ALXN2220) is a monoclonal antibody that targets human transthyretin (TTR). Cliramitug binds to TTR and inhibits its amyloidogenic process, exerting amyloid formation-inhibiting activity. Cliramitug can be used in the research of transthyretin amyloidosis-related diseases, such as certain neurological and cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-109165
CAS No.: 1446711-81-4
Purity:  99.23%
Synonyms: AG10
Target:  

Transthyretin (TTR)

Research Areas:  

Metabolic Disease Endocrinology

Acoramidis (AG10) is an orally active and selective kinetic stabilizer of WT and V122I-TTR (transthyretin). Acoramidis (AG10) is used in the study for transthyretin amyloidosis .
loading...
    loading...
Cat. No.: HY-109165A
CAS No.: 2242751-53-5
Purity:  98.56%
Synonyms: AG10 hydrochloride
Target:  

Transthyretin (TTR)

Research Areas:  

Metabolic Disease Endocrinology

Acoramidis (AG10) hydrochloride is an orally active and selective kinetic stabilizer of WT and V122I-TTR (transthyretin). Acoramidis (AG10) hydrochloride is used in the study for transthyretin amyloidosis .
loading...
    loading...
Cat. No.: HY-132590A
Purity:  93.16%
Synonyms: ALN-TTRSC sodium
Revusiran (ALN-TTRSC) sodium is an RNA interference agent targeting the mRNA of transthyretin (Transthyretin, TTR). Revusiran sodium mediates sequence-specific degradation of TTR mRNA through RNA interference, reduces the synthesis of TTR protein, binds to GalNAc ligands, and is taken up by hepatocytes via the asialoglycoprotein receptor. Revusiran sodium exhibits favorable nonclinical safety profiles. Revusiran sodium can be used in studies related to transthyretin-mediated amyloidosis .
loading...
    loading...
Cat. No.: HY-153609
Purity:  92.51%
AS-Patisiran sodium is an antisense strand of Patisiran. Patisiran is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran can be used for the research of hereditary TTR amyloidosis .
loading...
    loading...
Cat. No.: HY-P990734
CAS No.: 2626841-92-5

Target:  

Transthyretin (TTR)

Research Areas:  

Inflammation/Immunology

Coramitug is an anti-TTR human IgG1 κ monoclonal antibody . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-177650
Synonyms: ALN-TTRsc04
Target:  

Transthyretin (TTR)

Research Areas:  

Others

Nucresiran is a siRNA that inhibits hepatic synthesis of both wild-type and variant TTR mRNA.
loading...
    loading...
Cat. No.: HY-14852R
CAS No.: 594839-88-0
Tafamidis (Standard) is the analytical standard of Tafamidis. This product is intended for research and analytical applications. Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis .
loading...
    loading...